Stephens initiated coverage on shares of Treace Medical Concepts (NASDAQ:TMCI – Get Rating) in a research note released on Monday morning, Marketbeat.com reports. The brokerage issued an equal weight rating and a $26.00 target price on the stock. Separately, Morgan Stanley increased their price target on shares of Treace Medical Concepts from $28.00 to $30.00 […]